Čájehuvvojit 1 - 3 oktiibuot 3 bohtosis ohcui Yu-Ting Xu', ohcanáigi: 0,02s
Aiddostahte ozu
-
1
Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China Dahkki Qiran Wei, YuTing Xu, Wei Liu, Xin Guan
Almmustuhtton 2023-11-01
Artihkal -
2
An ion‐percolating electrolyte membrane for ultrahigh efficient and dendrite‐free lithium metal batteries Dahkki Yu‐Ting Xu, Sheng‐Jia Dai, Xiao‐Feng Wang, Xiong‐Wei Wu, Yu‐Guo Guo, Xian‐Xiang Zeng
Almmustuhtton 2023-12-01
Artihkal -
3
Joint-tissue integrative analysis identifies high-risk genes for Parkinson’s disease Dahkki Ya-Shi Wu, Ya-Shi Wu, Wen-Han Zheng, Tai-Hang Liu, Yan Sun, Yu-Ting Xu, Li-Zhen Shao, Qin-Yu Cai, Ya Qin Tang
Almmustuhtton 2024-03-01
Artihkal